Acid Reducer (Ranitidine) Tablet: N-nitrosodimethylamine (NDMA) impurity
Last updated
Summary
Product
Acid Reducer (Ranitidine) 75 mg Tablet; Maximum Strength Acid reducer (Ranitidine) 150 mg Tablet without prescription
Issue
Health products - Contamination
What to do
See instructions below.
Affected products
Brand / Marque | Product Name / Nom du produit | Market Authorization / Autorisation de mise en marché | Dosage Form / Forme posologique | Strength / Concentration | Lot number / Numéro de lot |
---|---|---|---|---|---|
Atoma | ATOMA-ACID RED MAX F 150mg C ALV 3X8 | DIN 02293471 | Tablet / Comprimé | Ranitidine 150 mg | 627765H |
Option+ | OPTION+ REDUC ACIDE 75mg COMP ALV 1x10 | DIN 02247551 | Tablet / Comprimé | Ranitidine 75 mg | 632952B |
Option+ | OPTION+ REDUC ACIDE 75mg COMP ALV 4X10 | DIN 02247551 | Tablet / Comprimé | Ranitidine 75 mg | 633694B |
Option+ | Option+ REDUC ACID F MAX 150mg CO ALV3X8 | DIN 02293471 | Tablet / Comprimé | Ranitidine 150 mg | 627765G |
Option+ | Option+ REDUC ACID F MAX 150mg CO AL 1X8 | DIN 02293471 | Tablet / Comprimé | Ranitidine 150 mg | 627765B |
Rexall Corp | Rexall Corp-REDUC ACIDE 150mg CO ALV 3X8 | DIN 02293471 | Tablet / Comprimé | Ranitidine 150 mg | 627765F |
Rexall Corp | Rexall Corp-REDUC ACIDE 150mg CO ALV 1X8 | DIN 02293471 | Tablet / Comprimé | Ranitidine 150 mg | 627765A |
Biomedic | BIOMEDIC REDUC ACIDE 75mg COMP ALV 3X10 | DIN 02247551 | Tablet / Comprimé | Ranitidine 75 mg | 632952I |
Biomedic | BIOMEDIC-ACID RED F MAX 150mg COM ALV3X8 | DIN 02293471 | Tablet / Comprimé | Ranitidine 150 mg | 627765I |
Biomedic | BIOMEDIC-ACID RED F MAX 150mg COM ALV3X8 | DIN 02293471 | Tablet / Comprimé | Ranitidine 150 mg | 628471C |
LD | LD-REDUC ACIDE F MAX 150mg COMP ALV 3X8 | DIN 02293471 | Tablet / Comprimé | Ranitidine 150 mg | 627765E |
Pharmasave | PHARMASAVE-RED ACID F MAX 150mg CO AL1X8 | DIN 02293471 | Tablet / Comprimé | Ranitidine 150 mg | 627765C |
Pharmasave | PHARMASAVE-RED ACID F MAX 150mg C ALV3X8 | DIN 02293471 | Tablet / Comprimé | Ranitidine 150 mg | 628471B |
Co-op Care + | CO-OP CARE + ACID REDU F M 150mg C AL3X8 | DIN 02293471 | Tablet / Comprimé | Ranitidine 150 mg | 627765D |
Compliments | Compliments-REDUC ACIDE 150mg C ALV 3X8 | DIN 02293471 | Tablet / Comprimé | Ranitidine 150 mg | 628471D |
Health One | Health One-REDUC ACIDE 150mg COM ALV 4X8 | DIN 02293471 | Tablet / Comprimé | Ranitidine 150 mg | 628471A |
Personnelle | Personnelle-REDUC ACIDE 75mg CO ALV1X10 | DIN 02247551 | Tablet / Comprimé | Ranitidine 75 mg | 632952D |
LB | LB-REDUC D'ACIDE 75mg COMP ALV 3X10 | DIN 02247551 | Tablet / Comprimé | Ranitidine 75 mg | 632952K |
Issue
Presence of N-nitrosodimethylamine (NDMA) above the acceptable concentration limit in affected lots.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Similar recalls or alerts
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Pharmasience Inc. Suite 100, 6111, Royalmount Avenue, Montreal, Quebec H4P 2T4 |
Published by
Health Canada
Audience
General public
Health professionals
Hospitals
Recall class
Type I
Identification number
RA-63679